Practical Considerations for the Management of Cushing's Disease and COVID-19 : A Case Report
Copyright © 2020 Beretta, Dassie, Parolin, Boscari, Barbot, Busetto, Mioni, De Carlo, Scaroni, Fallo, Vettor and Maffei..
Introduction: Italy, since the end of February 2020, is experiencing the corona virus disease 2019 (COVID-19) pandemic that may present as an acute respiratory infection. We report on COVID-19 pneumonia in the context of a complex case of Cushing's disease (CD). Case Report: A 67-year-old man with CD, who was admitted to our hospital, presented with signs and symptoms of adrenal insufficiency with persistent hypotension and glycemia toward the lower limits. We progressively withdrew almost all treatments for diabetes and CD (pasireotide and metyrapone), and i.v. hydrocortisone was necessary. A tendency to hyperkalemia was probably associated to enoxaparin. We summarized the many possible interactions between medications of Cushing's syndrome (CS) and COVID-19. Conclusion: Adrenal insufficiency might be a clinical challenge that needs a prompt treatment also in CS patients during COVID-19 infection. We should consider the possibility to titrate or temporary halt medical therapies of CS in the context of COVID-19 infection. Unexpected hyperkalemia in CS patients under treatment with heparin might be the signal of aldosterone suppression.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Frontiers in endocrinology - 11(2020) vom: 10., Seite 554 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Beretta, Federica [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-Inflammatory Agents |
|---|
| Anmerkungen: |
Date Completed 09.11.2020 Date Revised 18.12.2020 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.3389/fendo.2020.00554 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316413771 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316413771 | ||
| 003 | DE-627 | ||
| 005 | 20231225161029.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fendo.2020.00554 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1054.xml |
| 035 | |a (DE-627)NLM316413771 | ||
| 035 | |a (NLM)33071957 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Beretta, Federica |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Practical Considerations for the Management of Cushing's Disease and COVID-19 |b A Case Report |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.11.2020 | ||
| 500 | |a Date Revised 18.12.2020 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Beretta, Dassie, Parolin, Boscari, Barbot, Busetto, Mioni, De Carlo, Scaroni, Fallo, Vettor and Maffei. | ||
| 520 | |a Introduction: Italy, since the end of February 2020, is experiencing the corona virus disease 2019 (COVID-19) pandemic that may present as an acute respiratory infection. We report on COVID-19 pneumonia in the context of a complex case of Cushing's disease (CD). Case Report: A 67-year-old man with CD, who was admitted to our hospital, presented with signs and symptoms of adrenal insufficiency with persistent hypotension and glycemia toward the lower limits. We progressively withdrew almost all treatments for diabetes and CD (pasireotide and metyrapone), and i.v. hydrocortisone was necessary. A tendency to hyperkalemia was probably associated to enoxaparin. We summarized the many possible interactions between medications of Cushing's syndrome (CS) and COVID-19. Conclusion: Adrenal insufficiency might be a clinical challenge that needs a prompt treatment also in CS patients during COVID-19 infection. We should consider the possibility to titrate or temporary halt medical therapies of CS in the context of COVID-19 infection. Unexpected hyperkalemia in CS patients under treatment with heparin might be the signal of aldosterone suppression | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Cushing's disease | |
| 650 | 4 | |a SARS-Cov-2 | |
| 650 | 4 | |a hypercortisolism | |
| 650 | 4 | |a pituitary | |
| 650 | 4 | |a rare diseases | |
| 650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
| 650 | 7 | |a Antimetabolites |2 NLM | |
| 650 | 7 | |a Hydrocortisone |2 NLM | |
| 650 | 7 | |a WI4X0X7BPJ |2 NLM | |
| 650 | 7 | |a Metyrapone |2 NLM | |
| 650 | 7 | |a ZS9KD92H6V |2 NLM | |
| 700 | 1 | |a Dassie, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Parolin, Matteo |e verfasserin |4 aut | |
| 700 | 1 | |a Boscari, Federico |e verfasserin |4 aut | |
| 700 | 1 | |a Barbot, Mattia |e verfasserin |4 aut | |
| 700 | 1 | |a Busetto, Luca |e verfasserin |4 aut | |
| 700 | 1 | |a Mioni, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a De Carlo, Eugenio |e verfasserin |4 aut | |
| 700 | 1 | |a Scaroni, Carla |e verfasserin |4 aut | |
| 700 | 1 | |a Fallo, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Vettor, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Maffei, Pietro |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in endocrinology |d 2010 |g 11(2020) vom: 10., Seite 554 |w (DE-627)NLM208813357 |x 1664-2392 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2020 |g day:10 |g pages:554 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fendo.2020.00554 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2020 |b 10 |h 554 | ||